Northern Financial Advisors Inc Sells 1,134 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• Northern Financial Advisors Inc has reduced its stake in UnitedHealth Group by 38.7%, selling 1,134 shares, and now holds 1,797 shares valued at approximately $561,000.
• Analysts have raised their price targets for UnitedHealth Group, with Sanford C. Bernstein setting a new target of $379, while JPMorgan Chase & Co. lowered their target to $310.
• The company recently announced a quarterly dividend of $2.21, translating to an annualized dividend of $8.84 and a yield of 2.4% based on its payout ratio of 38.30%.

Northern Financial Advisors Inc cut its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 38.7% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,797 shares of the healthcare conglomerate's stock after selling 1,134 shares during the quarter. Northern Financial Advisors Inc's holdings in UnitedHealth Group were worth $561,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of the business. Vanguard Group Inc. raised its stake in UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock worth $47,519,620,000 after purchasing an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP raised its stake in UnitedHealth Group by 10.6% in the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock worth $13,537,859,000 after purchasing an additional 2,486,839 shares in the last quarter. Bank of New York Mellon Corp raised its stake in UnitedHealth Group by 2.5% in the 1st quarter. Bank of New York Mellon Corp now owns 8,128,174 shares of the healthcare conglomerate's stock worth $4,257,131,000 after purchasing an additional 196,696 shares in the last quarter. Nuveen LLC acquired a new position in shares of UnitedHealth Group in the 1st quarter valued at approximately $3,846,764,000. Finally, Charles Schwab Investment Management Inc. raised its position in shares of UnitedHealth Group by 13.6% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate's stock valued at $3,702,736,000 after buying an additional 847,054 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Analysts Set New Price Targets

UNH has been the subject of several analyst reports. Sanford C. Bernstein boosted their target price on shares of UnitedHealth Group from $337.00 to $379.00 and gave the company an "outperform" rating in a research report on Friday, September 5th. Bank of America boosted their target price on shares of UnitedHealth Group from $290.00 to $325.00 and gave the company a "neutral" rating in a research report on Monday, August 18th. Truist Financial lifted their price target on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a "buy" rating in a report on Tuesday, September 9th. UBS Group reaffirmed a "buy" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Finally, JPMorgan Chase & Co. decreased their price target on shares of UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating on the stock in a report on Wednesday, August 6th. Sixteen analysts have rated the stock with a Buy rating, six have given a Hold rating and four have assigned a Sell rating to the company. According to MarketBeat.com, UnitedHealth Group has an average rating of "Hold" and a consensus price target of $365.00.

UnitedHealth Group Trading Up 1.4%

UNH opened at $363.95 on Wednesday. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The firm has a market capitalization of $329.62 billion, a price-to-earnings ratio of 15.77, a PEG ratio of 2.33 and a beta of 0.47. The company's 50 day moving average price is $311.44 and its two-hundred day moving average price is $352.42.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm's revenue for the quarter was up 12.9% on a year-over-year basis. During the same quarter last year, the firm posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were given a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.4%. UnitedHealth Group's payout ratio is 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.